Case Study: Benefits of Post-Acute Nursing Facility vs. Home Care

When a patient is released from the hospital, patient advocates often believe their best chance for recovery and avoidance of readmission is in-home medical care and rehabilitation versus admittance into a skilled nursing facility (SNF). During hospitalization, however, it’s challenging to envision the in-home post-acute care needs for each unique patient. Thus, it’s not a simple narrative on which option will best facilitate a quick and full recovery.

The Determining Factors

To gain better insight, a study by Penn State University Leonard Davis Institute of Health Economics (LDI) looked to determine the differences in 30-day readmission rates, 30-day mortality rates, functional outcomes, and Medicare costs between those patients discharged to home health and those to an SNF. The assessment factors were unique in that the research used a large data set (17 million Medicare beneficiary hospitalizations), controls for patient characteristics across care settings, and included patients with many different ailments.

The Findings

During 2010 and 2016, of the more than 17 million discharges considered in the study, over 40% of the patients received some type of post-acute services—39% were released into a home care setting and 61% to an SNF. While those discharged to home rehab had a 5.6% higher readmission rate at 30 days than those in the SNF category, it is assumed that the 24-hour monitored care and higher level of treatment provided by an SNF reduced the likelihood of post-acute complications. However, the slightly higher readmission rates of home-recovery patients were not attributed to life-threatening symptoms such as respiratory failure but were based on potential cautionary reasons at the caregiver’s or patient’s discretion.

When it comes to costs, the average savings per patient discharged to in-home care was $5,385 less than patients admitted to SNFs. Further, the total Medicare payment within the first 60 days following hospitalization was also less for the home health care group, with a savings of $4,514 per patient. Interestingly enough, though, the study found no difference in improved patient functionality from the home health setting versus a SNF, nor were their disparities in mortality rates between each group. While the study correlates fewer readmissions with SNFs, these facilities did incur significantly increased Medicare spending per patient.

Clinicians must be able to balance the benefits of both settings to ensure the best outcome for their patients. Additional research to better understand which patient profiles would most benefit from SNF care or may be less likely to be readmitted after discharge to home health care could provide vital insight for caregivers and hospitals alike.

Help for Home Caretakers

When a patient is released to in-home care, their family or friends are often the ones tasked with helping in their recovery. This care typically involves changing dressings, managing medications, and the operation of fundamental medical equipment. AliMed is committed to providing patients and caregivers with a wide selection of quality at-home specialty healthcare products designed to improve quality of life and promote safer, easier, and more independent living. Click here to learn more.

Follow us on social media for the latest updates in B2B!

Image

Latest

visitor management solution
Reinventing Visitor Management Solution with Symmetry GUEST
April 2, 2025

In an age where speed and security are paramount, the traditional paper logbook is becoming a relic of the past. AMAG Technology’s Symmetry Guest system offers a modern, digital solution that redefines the way organizations welcome and manage visitors. Gone are the days of long lines and confusion at the front desk—Symmetry Guest empowers hosts…

Read More
AMAG
Driven by Customers, Defined by Innovation: Inside AMAG’s Customer-Obsessed Approach
April 2, 2025

AMAG Technology continues to strengthen its customer-obsessed culture by actively listening to both internal and external voices. As shared by Kyle Gordon, Executive Vice President of Global Sales, Marketing, & Commercial Excellence, the company is focused on improving processes, responding with speed, and driving innovation—while honoring its legacy and delivering unique value within the industry.

Read More
biotech
Biotech Moves Smarter: IDDI Powers Data-Driven Drug Innovation
April 2, 2025

As biotech innovation accelerates, small and mid-size pharmaceutical companies are becoming key players in bringing new treatments to market. Yet many of these organizations face steep challenges when navigating clinical trial design, regulatory approval, and data integrity. According to a McKinsey Global Institute report, industries like biotech could help generate up to $50 trillion…

Read More
AMAG Technology
AMAG Technology Drives Positive Change, Product Innovation, and Stronger Partnerships with the Customer in Mind
April 2, 2025

At AMAG Technology, customer obsession is at the heart of everything the company does. Customer Relationship Manager Aimee Walsh shares how AMAG embraces positive change, enhances its products, and strengthens partnerships—all with the customer in mind. Her insights reflect AMAG’s ongoing commitment to evolving alongside customer needs and delivering meaningful solutions.

Read More